Previous studies showed that migration and invasion of HT-29 cell line was not significantly changed following treatment with IL-10 [36], however, in murine models of breast and melanoma cancers IL-10 showed anti-metastatic effects [37]. This evidence concerns the gene IL10 and melanoma.